Perkins Capital Management Inc Gilead Sciences, Inc. Transaction History

Perkins Capital Management Inc

$102 Million
Q3 2024

A detailed history of Perkins Capital Management Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Perkins Capital Management Inc holds 10,933 shares of GILD stock, worth $986,047. This represents 0.9% of its overall portfolio holdings.

Number of Shares

10,933

Previous 12,433 12.06%

Holding current value

$986,047

Previous $853,000 7.39%

% of portfolio

0.9%

Previous 0.84%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$66.59 - $83.99 $99,885 - $125,984	-1,500 Reduced 12.06%	10,933 $916,000
Q2 2024 Aug 09, 2024	SELL	$63.15 - $72.88 $31,575 - $36,440	-500 Reduced 3.87%	12,433 $853,000
Q1 2024 May 09, 2024	SELL	$71.58 - $87.29 $3,579 - $4,364	-50 Reduced 0.39%	12,933 $947,000
Q4 2023 Jan 22, 2024	SELL	$73.27 - $83.09 $43,962 - $49,854	-600 Reduced 4.42%	12,983 $1.05 Million
Q3 2023 Nov 02, 2023	SELL	$73.94 - $80.67 $2,513 - $2,742	-34 Reduced 0.25%	13,583 $1.02 Million
Q1 2023 May 09, 2023	SELL	$77.31 - $88.08 $15,462 - $17,616	-200 Reduced 1.45%	13,617 $1.13 Million
Q4 2022 Jan 26, 2023	SELL	$62.32 - $89.47 $31,160 - $44,735	-500 Reduced 3.49%	13,817 $1.19 Million
Q3 2022 Oct 24, 2022	SELL	$59.54 - $68.01 $77,402 - $88,413	-1,300 Reduced 8.32%	14,317 $883,000
Q2 2022 Jul 29, 2022	SELL	$57.72 - $65.01 $8,658 - $9,751	-150 Reduced 0.95%	15,617 $965,000
Q4 2021 Feb 10, 2022	SELL	$64.88 - $73.64 $34,581 - $39,250	-533 Reduced 3.27%	15,767 $1.15 Million
Q3 2021 Oct 25, 2021	BUY	$67.69 - $73.03 $60,921 - $65,727	900 Added 5.84%	16,300 $1.14 Million
Q2 2021 Jul 28, 2021	BUY	$63.47 - $69.35 $196,757 - $214,984	3,100 Added 25.2%	15,400 $1.06 Million
Q1 2021 Apr 28, 2021	BUY	$60.0 - $68.46 $12,000 - $13,691	200 Added 1.65%	12,300 $795,000
Q4 2020 Feb 09, 2021	BUY	$56.65 - $64.55 $67,980 - $77,460	1,200 Added 11.01%	12,100 $705,000
Q3 2020 Oct 28, 2020	BUY	$62.1 - $78.08 $18,630 - $23,424	300 Added 2.83%	10,900 $689,000
Q1 2020 Apr 29, 2020	BUY	$62.63 - $80.22 $663,878 - $850,332	10,600 New	10,600 $792,000

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perkins Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perkins Capital Management Inc with notifications on news.

Account

Perkins Capital Management Inc Gilead Sciences, Inc. Transaction History